Author: Alligator Bioscience

Posted Date:

May 22, 2026

Alligator Bioscience Comments on Henlius Update on Long-Term Follow-Up Data for HLX22

Alligator Bioscience

May 22, 2026
Bulletin from The Annual General Meeting in Alligator Bioscience AB on 6 May 2026

Alligator Bioscience

May 6, 2026
Alligator Bioscience AB Reports Financial Results for The Period 1 January – 31 March 2026 and Provides a Business Update

Alligator Bioscience

May 5, 2026
Invitation to Alligator Bioscience’s Earnings Call on 5 May 2026

Alligator Bioscience

April 28, 2026
Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026

Alligator Bioscience

April 23, 2026
New Data from Investigator‑Initiated Study Evaluating Alligator Bioscience’s Mitazalimab to Be Presented at AACR Annual Meeting 2026

Alligator Bioscience

April 20, 2026
Alligator Bioscience Provides an Update on Mitazalimab

Alligator Bioscience

April 10, 2026
Notice of Annual General Meeting in Alligator Bioscience AB

Alligator Bioscience

March 30, 2026
The Nomination Committee’s Proposals Regarding the Board of Directors for the Annual General Meeting in Alligator Bioscience AB (publ)

Alligator Bioscience

March 27, 2026
Alligator Bioscience Publishes Annual Report for 2025

Alligator Bioscience

March 26, 2026